- Home
- »
- Renewable Chemicals
- »
-
Chitosan Market Size, Share, Trends & Growth Report, 2033GVR Report cover
Chitosan Market (2026 - 2033)
Size, Share & Trends Analysis Report By Application (Water Treatment, Medical & Pharmaceutical, Cosmetics, Food & Beverages, Agrochemicals, Others), By Region, And Segment Forecasts
Market Size, 2025
$18.6BMarket Estimate, 2026
$22.4BMarket Forecast, 2033
$83.5BCAGR, 2026–2033
20.3%Chitosan Market Summary
The global chitosan market size was valued at USD 18.6 billion in 2025 and is projected to grow from USD 22.4 billion in 2026 to USD 83.5 billion by 2033, at a CAGR of 20.7% from 2026 to 2033. Asia Pacific dominated the market, accounting for a revenue share of 44.4% in 2025. The growth is attributed to the increasing demand for naturally derived products and their high penetration in waste-water treatment, pharmaceutical, and cosmetics applications.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By application: Biomedical held a dominant position, contributing 30.4% of total revenue in 2025.
Regional Highlights
- Largest regional market: Asia Pacific (44.4% revenue share, 2025)
- By country: The U.S. held the largest market share in 2025.
Market Size & Forecast
- Market size in 2025: USD 18.6 Billion
- Estimated market size in 2026: USD 22.4 Billion
- Projected market size by 2033: USD 83.5 Billion
- CAGR (2026-2033): 20.7%
Three ways to get this report
Buy it, customize it, or ask a question.Ask an Analyst
Analyst response in 1 business day
- AccessReport author, directly
- Reply timeWithin 1 working day
- No sales callDirect answer only
- FormatEmail reply
- CostFree, no cost
Get the Full Report
What the study covers
- FormatsPDF · Excel · Dashboard
- Timeline2026–2033 annual, 2025 base
- Coverage20+ countries, 5 regions
- Companies10+ key players profiled
Customize the Report
20% free customization
- IncludeCountries, segments, points
- TailorTo your product definition
- ExtendDeeper competitor detail
- OrA fully bespoke study
- Turnaround5–10 working days
Chitosan is expected to witness high demand from the food & beverage industry owing to favorable regulatory support by the developed economies and increasing awareness concerning the health benefits offered by the product. In addition, surging demand for the product as a food preservative and stabilizer has contributed to market growth. Furthermore, the rising utilization of the product as a clarifying agent in juices, as a thickening agent in beverages, and in packaging food products is anticipated to propel the demand.
To learn more about this report,Download Free Sample Report
Shrimp shells, crab shells, and squid pens are the most prominent raw materials used to produce chitin and chitosan. Chitosan is available in three varieties: alpha, beta, and gamma. Alpha and beta chitosan are the most widely available products manufactured using shrimp/crab shells and squid pens, respectively. The various types of chitosan differ in their chitin strand structure, which determines the characteristics and properties of the chitosan manufactured.
One of the market growth drivers, especially in the Asia-Pacific region, is the abundant availability of raw materials. It is one of the most abundant biopolymers and a significant waste product in the fishery industry. Chitosan is primarily obtained from various materials, including shrimp & crab shells and squid pens. Traditionally, these wastes were discarded or used directly as fertilizers. In addition, remarkable research on chitosan during the past few decades has revealed its significant importance in various applications, including wastewater treatment, pharmaceuticals, and food & beverage.
However, initiatives taken by manufacturers and researchers to improve purity to meet the required standards are expected to open new avenues for the existing and new market players during the forecasted period. In addition, rising demand for chitosan as an antibacterial, anti-cancerous, anti-inflammatory, and anti-fungal agent in pharmacological applications is expected to drive demand during the forecast period.
Market Dynamics
The chitosan market is witnessing sustained growth, driven by increasing demand for biodegradable, non-toxic, and bio-based materials across multiple industries. Growing environmental regulations and the transition toward sustainable alternatives are encouraging the adoption of chitosan in water treatment, where it is valued for its natural flocculation and heavy metal adsorption capabilities. In the pharmaceutical and biomedical sectors, advancements in drug delivery systems, wound care products, and tissue engineering are expanding commercial applications due to chitosan's biocompatibility and antimicrobial properties. Rising consumer preference for clean-label food ingredients and naturally derived cosmetic formulations is further supporting market expansion. Continuous research focused on improving extraction technologies, product purity, and functional performance is creating opportunities for premium-grade chitosan products. However, fluctuations in the availability and pricing of crustacean-derived raw materials, along with stringent regulatory requirements for medical and food applications, present challenges for manufacturers.
The growing emphasis on environmental sustainability is a primary factor driving the chitosan market, as industries increasingly replace synthetic chemicals with renewable and biodegradable alternatives. Chitosan, derived from natural sources such as crustacean shells and fungal biomass, offers biodegradability, biocompatibility, and low toxicity, making it suitable for applications where regulatory compliance and environmental performance are becoming critical purchasing criteria. Governments and regulatory authorities are also promoting the adoption of eco-friendly materials through stricter environmental policies, encouraging manufacturers to incorporate bio-based ingredients into their product portfolios. This shift is accelerating the commercialization of chitosan across industrial and consumer applications.
The demand for sustainable materials is particularly evident in water treatment, food processing, cosmetics, and healthcare, where end users are seeking products with reduced environmental impact while maintaining high functional performance. Chitosan's ability to act as a natural flocculant, antimicrobial agent, film-forming polymer, and stabilizing ingredient enhances its value proposition across these sectors. As companies continue investing in circular economy initiatives and sustainable supply chains, the integration of bio-based polymers such as chitosan is expected to expand, supporting long-term market growth and creating opportunities for product innovation.
A major restraint affecting the chitosan market is its dependence on crustacean-derived raw materials and the stringent regulatory standards governing its use in pharmaceutical, biomedical, and food applications. The availability and pricing of shrimp and crab shells are influenced by seasonal harvesting patterns, seafood processing volumes, and regional supply chain disruptions, leading to fluctuations in production costs and raw material availability. In addition, manufacturers must comply with rigorous quality, purity, traceability, and safety requirements before products can be approved for high-value applications, particularly in healthcare and food industries. Achieving consistent molecular weight, degree of deacetylation, and product performance requires advanced processing technologies and strict quality control systems, increasing production complexity and operational costs. These challenges can limit market entry for smaller manufacturers, extend product commercialization timelines, and constrain broader adoption in highly regulated end-use sectors.
The increasing development of advanced healthcare technologies presents a significant growth opportunity for the chitosan market. Owing to its excellent biocompatibility, biodegradability, and mucoadhesive properties, chitosan is gaining wider acceptance in drug delivery systems, wound healing products, tissue engineering, and regenerative medicine. Pharmaceutical and biotechnology companies are investing in novel biomaterial platforms that improve therapeutic effectiveness while minimizing adverse effects, positioning chitosan as an important functional ingredient in next-generation medical solutions. Continuous innovation in biomaterials is expected to expand the commercial adoption of high-purity chitosan in specialized healthcare applications.
Growing investments in biomedical research, personalized medicine, and medical device development are further strengthening market opportunities. Researchers are exploring chitosan-based nanoparticles, hydrogels, scaffolds, and bioactive coatings to enhance targeted drug delivery and tissue regeneration. At the same time, increasing healthcare expenditure and the rising prevalence of chronic diseases are creating demand for advanced wound management products and implantable biomaterials. As regulatory approvals for innovative biomaterial-based products continue to increase and manufacturing technologies become more sophisticated, suppliers capable of delivering pharmaceutical-grade chitosan with consistent quality are likely to benefit from higher-value market segments.
Analyst Perspective
The chitosan market is poised for sustained growth, supported by increasing demand for bio-based, biodegradable materials across healthcare, water treatment, food, and personal care industries. Advancements in biomedical applications, particularly drug delivery and regenerative medicine, are expanding the commercial potential of high-purity chitosan. Regulatory emphasis on sustainable materials and circular economy initiatives is further accelerating adoption across industrial sectors. While raw material availability and stringent quality standards remain key challenges, ongoing investments in fungal-derived chitosan and advanced processing technologies are expected to strengthen supply resilience. Companies that focus on innovation, regulatory compliance, and application-specific product development are well positioned to capitalize on emerging high-value opportunities.
Application Insights
By application, biomedical held a dominant position, contributing 30.4% of total revenue in 2025. This is attributed to the increasing demand for bio-based ingredients in drug manufacturing. High investments in the pharmaceutical and medical sectors, coupled with demand for advanced healthcare products, are expected to impact market growth during the forecast period positively.
On the other hand, increasing demand for bio-derived personal care products is expected to be a key driver for market growth. Chitosan's bacteriostatic and fungistatic properties are expected to open new avenues for the product market in cosmetic applications. Increasing demand for chitosan used for skin and hair care cream manufacturing as a hydrating agent will likely drive market growth.
The rising application scope of chitosan for manufacturing dental care products, including mouthwash, toothpaste, and tooth gels, will likely increase demand for these products. The increasing application scope of chitosan for manufacturing color cosmetics such as lipsticks, eye shadows, and nail polishes is expected to propel demand during the forecast period. Furthermore, the rising demand for chitosan to treat various skin problems, including acne and scars, will likely drive the growth.
Regional Insights
Asia Pacific dominated the chitosan market with the highest revenue share of 44.4% in 2025. China dominated the Asia Pacific chitosan market in 2025. This is attributed to the Asia Pacific region having emerged as a dominant force in the market, driven by a combination of factors that enhance its position in the global landscape. As of 2023, the market in this region is experiencing significant growth, with projections indicating that it will continue to expand rapidly in the coming years.
To learn more about this report,Download Free Sample Report
Asia Pacific is growing significantly during the forecast period. The growing demand for skin care products, especially among women and teenagers, is anticipated to positively impact the product market during the forecast period. The growing fashion industry and increasing demand for naturally derived hair and skin care products in the region are expected to propel demand throughout the forecasted period. Growing investments in municipal wastewater treatment and the increasing use of bio-derived chemicals in the field are expected to drive the demand during the forecast period.
The pharmaceutical industry in Canada is considered one of the most profitable sectors and has been the fourth fastest-growing healthcare industry after China, U.S., and Spain. As a result, a positive pharmaceutical industry outlook in Canada is likely to fuel the demand. The robust manufacturing base of global cosmetic producers such as Johnson & Johnson, Unilever, and Procter & Gamble in the U.S. is expected to promote demand for chitosan in formulating personal care products.
Key Chitosan Company Insights
Some of the key players operating in Panvo Organics Pvt. Ltd, Qingdao Yunzhou Biochemistry Co.,Advanced Biopolymers AS3, Meron Biopolymers:
-
Qingdao Yunzhou Biochemistry Co., Ltd. is a biotechnology company based in Qingdao, Shandong, China. The company specializes in producing and supplying chitosan-based products, which are derived from chitin, a natural polymer found in crustaceans' shells.
-
Panvo Organics Pvt. Ltd. is a prominent manufacturer based in Chennai, India, specializing in Active Pharmaceutical Ingredients (APIs), Nutraceutical Ingredients, and Specialty Chemicals. Established in 2006, the company has rapidly become a key player in producing Glucosamine and Chitosan, among other products.
Key companies are adopting several organic and inorganic growth strategies to maintain and expand their market share, such as capacity expansion, mergers & acquisitions, and joint ventures.
Key Chitosan Companies:
The following key companies have been profiled for this study on the chitosan market.
-
Qingdao Yunzhou Biochemistry Co.
-
Panvo Organics Pvt. Ltd.
-
Advanced Biopolymers AS
-
Meron Biopolymers
-
Biophrame Technologies
-
United Chitotechnologies Inc.
-
Heppe Medical Chitosan GmbH
-
KitoZyme S.A.
-
Foodchem International Corporation
-
Chitosanlab
-
FMC Corporation
-
Golden-Shell Pharmaceutical Co. Ltd.
-
Primex EHF
-
Nano3Bio
-
Koyo World (Hong Kong) Co. Ltd.
-
Dainichiseika Color & Chemicals Mfg. Co. Ltd.
-
KYTOSAN LLC
Competitive Benchmarking
Category
Operating Strategies
Competitive Edge
Weakness
Established Players (FMC Corporation, Dainichiseika Color & Chemicals Mfg. Co. Ltd., Golden-Shell Pharmaceutical Co. Ltd., Primex EHF, KitoZyme S.A., Heppe Medical Chitosan GmbH, Foodchem International Corporation, Qingdao Yunzhou Biochemistry Co., Advanced Biopolymers AS, United Chitotechnologies Inc.)
- Focus on large-scale production supported by vertically integrated sourcing and established global distribution networks.
- Invest continuously in product innovation, high-purity chitosan grades, and application-specific formulations for regulated industries.
- Strengthen market presence through long-term supply agreements, strategic partnerships, and expansion into high-growth regional markets.
- Emphasize regulatory compliance, quality certifications, and sustainable manufacturing practices to serve pharmaceutical, biomedical, and food applications.
- Strong brand recognition and long-standing relationships with global customers across multiple end-use industries.
- Extensive manufacturing capacity enables consistent supply, economies of scale, and competitive pricing.
- Broad product portfolios addressing industrial, healthcare, food, cosmetic, and environmental applications reduce dependence on a single market.
- Well-established R&D capabilities facilitate continuous product development and faster commercialization of advanced chitosan solutions.
- Higher operational costs associated with maintaining large production facilities and stringent regulatory compliance.
- Greater exposure to fluctuations in crustacean-derived raw material availability due to high production volumes.
- Organizational complexity can slow decision-making and delay responses to rapidly changing customer requirements.
- Significant capital investment requirements may reduce operational flexibility during periods of market uncertainty.
Emerging Players (Panvo Organics Pvt Ltd, Meron Biopolymers, Biophrame Technologies, Chitosanlab, Nano3Bio, Koyo World (Hong Kong) Co. Ltd., KYTOSAN LLC.)
- Target niche and specialized applications with customized chitosan formulations tailored to specific customer requirements.
- Prioritize research collaborations with academic institutions, biotechnology firms, and healthcare organizations to accelerate innovation.
- Expand market reach by developing sustainable and fungal-derived chitosan products for premium applications.
- Focus on regional expansion through distributor partnerships and digital sales channels while optimizing production efficiency
- Greater operational flexibility allows rapid product customization and faster response to evolving market trends.
- Strong emphasis on innovation enables entry into emerging biomedical, pharmaceutical, and specialty material applications.
- Lean organizational structures support quicker commercialization of new technologies and customer-focused product development.
- Ability to differentiate through specialized, high-value products rather than competing primarily on production volume.
- Limited manufacturing capacity can restrict the ability to serve large-volume commercial contracts.
- Lower brand visibility compared with established multinational competitors may slow customer acquisition.
- Constrained financial resources may limit investments in advanced production technologies, regulatory approvals, and global expansion.
- Smaller distribution networks and geographic presence can reduce market penetration and supply chain resilience.
Recent Development
-
In September 2023, Heppe Medical Chitosan (HMC) introduced the first-ever chitosan molecular weight standards at EUCHIS. This innovation enables researchers and customers to utilize dependable chitosan for molecular weight analysis without comparing them to other materials.
-
In November 2022, Chitogen Inc., a U.S.-based medical manufacturing company, signed a letter of intent with Tru Shrimp to purchase commercial quantities of chitosan produced from the ground-up exoskeleton of its farm-raised shrimp. This move was made to build a large-scale shrimp farm in South Dakota, U.S.
-
In September 2021, KitoZyme launched a new version of its vegan chitosan at Vitafoods. KitoZyme has developed a patented process for producing chitin and chitosan from fungi on an industrial scale. This breakthrough innovation has significantly impacted these biopolymers' perception and potential applications.
Chitosan Market Report Scope
Report Attribute
Details
Market size in 2025
USD 18.6 billion
Estimated market size in 2026
USD 22.4 billion
Projected market size by 2033
USD 83.5 billion
Growth rate
CAGR of 20.7% from 2026 to 2033
Base year for estimation
2025
Historical data
2021 - 2024
Forecast period
2026 - 2033
Quantitative units
Revenue in USD billion/billion, Volume in Kilotons and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Application, region
Regional scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope
U.S.; Canada; Mexico; Germany; UK; France; Italy; Spain; China; India; Japan; South Korea; Vietnam; Brazil; Saudi Arabia; South Africa
Key companies profiled
British Petroleum; Chevron Corporation; China National Petroleum Corporation (CNPC); Valero Energy Corporation; Conocco Phillips Inc.; Devron Energy Corporation; Exxon Mobil Corporation; Perenco; Royal Dutch Shell plc; Linde AG; TotalEnergies; Praxair
Customization scope
Free report customization (equivalent up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Chitosan Market Report Segmentation
This report forecasts volume and revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global chitosan market report based on application, and region:
To learn more about this report,Download Free Sample Report
-
Application Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
-
Water Treatment
-
Pharmaceutical
-
Biomedical
-
Cosmetics
-
Food & Beverage
-
Others
-
-
Regional Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
-
Asia Pacific
-
China
-
Japan
-
South Korea
-
India
-
Singapore
-
-
Central & South America
-
Brazil
-
Argentina
-
-
Middle East & Africa
-
Saudi Arabia
-
South Africa
-
-
Research Methodology
The chitosan market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing - reconciling supply-side and demand-side estimates - and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each chitosan segment quantified using the revenue-capture definitions in the table below.
Segment Definition
Segment - Application
Revenue capture definition
Water Treatment
Market earnings are generated through the commercialization of chitosan-based coagulants and flocculants used for wastewater purification, drinking water treatment, heavy metal removal, and sludge management across municipal and industrial facilities.
Pharmaceutical
Business proceeds originate from the incorporation of chitosan into drug delivery systems, tablet formulations, vaccine adjuvants, pharmaceutical excipients, and controlled-release therapeutics designed to enhance treatment efficacy.
Biomedical
Financial returns stem from the deployment of chitosan in wound dressings, tissue engineering scaffolds, surgical materials, regenerative medicine, and other biocompatible healthcare products requiring advanced biomaterials.
Cosmetics
Industry revenue is obtained from the use of chitosan in skincare, haircare, oral care, and personal care formulations where it functions as a film former, moisturizer, conditioning agent, and texture enhancer.
Food & Beverage
Sales are driven by the integration of chitosan into food preservation systems, edible coatings, beverage clarification, dietary supplements, and functional ingredients that improve product quality, stability, and shelf life.
Other Applications
Income is realized from the adoption of chitosan in agriculture, animal nutrition, textiles, packaging, paper processing, biotechnology research, and various specialty industrial applications requiring biodegradable polymer solutions.
Estimation Model
Layer Name
Key Question
Description
Raw Material & Production Layer
What forms the supply base?
Examine the global supply ecosystem for chitosan by assessing the availability of crustacean shells (shrimp, crab, and lobster) and fungal biomass used as primary feedstocks. The analysis includes raw material sourcing, demineralization and deacetylation processes, production technologies, manufacturing capacity, quality standards, supplier networks, and regional production hubs that ensure a stable commercial supply.
Application Adoption Layer
Where is chitosan utilized?
Evaluate the adoption of chitosan across water treatment, pharmaceutical, biomedical, cosmetics, food & beverage, agriculture, and other industrial applications. Demand is supported by increasing preference for biodegradable materials, expanding healthcare innovations, clean-label product development, environmental regulations, and the growing use of bio-based polymers in high-value end-use industries.
Consumption Intensity Layer
How much chitosan is utilized?
Assess consumption patterns by examining product uptake across major end-use sectors, considering formulation requirements, manufacturing output, regulatory approvals, customer adoption rates, regional demand variations, import-export activity, and industry-specific utilization trends to estimate overall market consumption.
Revenue Layer
How is market revenue generated?
Market value is created through the production, purification, formulation, and commercialization of chitosan supplied to manufacturers operating in healthcare, food processing, cosmetics, water treatment, and specialty industrial sectors. Business expansion is supported by technological advancements, premium-grade product offerings, strategic collaborations, application diversification, regulatory compliance, and investments in sustainable biomaterial manufacturing.
Delivered Customizations
This report has been delivered with the following In-depth customizations
Client Request
Customization Delivered
Value Adds
Cross-segmentation
The assessment examines market performance across application categories, end-use industries, regional demand patterns, manufacturing capabilities, raw material availability, pricing trends, and distribution channels for chitosan. It further evaluates adoption across water treatment, pharmaceutical, biomedical, cosmetics, food & beverage, and other applications while analyzing competitive positioning, technological advancements, and evolving customer requirements.
Enables stakeholders to identify high-growth applications, compare regional demand trends, evaluate manufacturing capabilities, understand sector-specific growth drivers, and formulate effective expansion, product development, and investment strategies.
Competitive benchmarking
The report provides a comprehensive evaluation of leading manufacturers based on product portfolios, geographic footprint, technology strengths, strategic initiatives, quality certifications, partnerships, and innovation activities. It also analyzes competitive positioning, capacity expansion, raw material sourcing strategies, and differentiation across key end-use markets.
Supports strategic decision-making by identifying competitive advantages, benchmarking operational capabilities, evaluating innovation strategies, strengthening supplier selection, and uncovering opportunities for market differentiation and long-term business growth.
Opportunity Assessment
The study delivers an in-depth evaluation of growth prospects across water treatment, pharmaceutical, biomedical, cosmetics, food & beverage, agriculture, and other emerging applications. It further assesses opportunities arising from increasing demand for biodegradable materials, expanding biomedical research, clean-label product innovation, sustainable manufacturing initiatives, and advancements in high-purity and fungal-derived chitosan technologies.
Assists organizations in prioritizing high-value application areas, identifying attractive investment prospects, aligning business strategies with sustainability and healthcare trends, strengthening competitive positioning, and capturing long-term growth through innovation and application diversification.
Frequently Asked Questions About This Report
The global chitosan market is expected to grow at a CAGR of 20.3% from 2026 to 2033, reaching USD 83.5 billion by 2033.
The global chitosan market size was valued at USD 18.6 billion in 2025 and is estimated at USD 22.4 billion in 2026.
By application, biomedical held a dominant position, contributing 30.4% of total revenue in 2025. Its dominance is attributed to the increasing use of chitosan in wound healing products, tissue engineering, drug delivery systems, and other advanced medical applications requiring biocompatible and biodegradable materials.
The chitosan market is primarily driven by rising demand for biodegradable and bio-based materials across water treatment, healthcare, food, and personal care industries. Expanding applications in drug delivery, wound care, and sustainable packaging, coupled with increasing environmental regulations promoting eco-friendly alternatives, are further accelerating market growth.
Some key players operating in the chitosan market include Qingdao Yunzhou Biochemistry Co.; Panvo Organics Pvt Ltd; Advanced Biopolymers AS; Meron Biopolymers; Biophrame Technologies; United Chitotechnologies Inc. and others.
Asia Pacific dominated the chitosan market with the highest revenue share of 44.4% in 2025. The region's leadership is supported by abundant crustacean raw material availability, well-established manufacturing capabilities, expanding pharmaceutical and water treatment industries, and rising demand for bio-based materials across major economies.
About the Author(s)
Renewable Chemicals Research Team
Specialty & Chemicals · Renewable ChemicalsThis report was authored by the renewable chemicals research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the renewable chemicals segment of the specialty & chemicals industry. All findings are based on proprietary specialty & chemicals databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.